DNA repair proteins serve as the body’s molecular editors, constantly detecting and fixing damage to our genetic code. One such protein, polymerase theta (Pol-theta), has been a critical focus in cancer research for its role in aiding the survival of cancer cells. For years, scientists have been working to understand how cancer cells exploit Pol-theta to bypass standard DNA repair mechanisms. Now, a team at Scripps Research has made a significant breakthrough by capturing the first high-resolution images of Pol-theta in action, offering crucial insights into its role in cancer development.
Published in Nature Structural & Molecular Biology on February 28, 2025, the study reveals that Pol-theta undergoes a significant structural change when binding to broken DNA strands, shedding light on how it functions in cancer cells. This discovery provides a foundation for developing more targeted and effective cancer therapies aimed at blocking Pol-theta’s activity.
Continue reading… “Uncovering Pol-theta’s Role in Cancer: A New Target for Precision Therapy”